Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases

NCT06756633
completed

SLP Model Development in the Diagnosis of COPD Patients

NCT04584801
completed

Structured Light Plethysmography in Obstructive Airways Disease

NCT03499938
completednot_applicable

Validation of Structured Light Plethysmography

NCT02598336

Clinical Trials (4)

Showing 4 of 4 trials
NCT06756633

Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases

Recruiting
NCT04584801

SLP Model Development in the Diagnosis of COPD Patients

Completed
NCT03499938

Structured Light Plethysmography in Obstructive Airways Disease

Completed
NCT02598336Not Applicable

Validation of Structured Light Plethysmography

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4